Terminology Service for NFDI4Health
All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| (-)-DCA-CL | CHEBI_132247 | [A member of the class of 1-benzofurans that is a lignan obtained by cyclodimerisation of ferulic acid.] |
| (-)-DCA-CC | CHEBI_132249 | [A member of the class of 1-benzofurans that is a lignan obtained by cyclodimerisation of ferulic acid.] |
| 4,4,4-trifluoro-N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide | CHEBI_106960 | |
| N-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide | CHEBI_106961 | |
| 1-(4-fluorophenyl)-3-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea | CHEBI_106962 | |
| [6)-[alpha-Neup5Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)]-beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1->]n | CHEBI_131940 | [A polysaccharide derivative with a repeating unit consisting of beta-D-galactosyl, beta-D-galactosyl and beta-D-glucosyl residues linked sequentially (1->3) and (1->4), to the galactosyl residue at the non-reducing end of which is attached an N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl trisaccharide unit via a (1->3) linkage, with all repeating units being linked (1->6). Capsular polysaccharide of Streptococcus suis serotype 14.] |
| 1-cyclohexyl-3-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea | CHEBI_106963 | |
| EC 3.2.1.28 (alpha,alpha-trehalase) inhibitor | CHEBI_83762 | [An EC 2.4.1.* (hexosyltransferase) inhibitor that interferes with the action of alpha,alpha-trehalase (EC 2.4.1.28).] |
| antibiotic insecticide | CHEBI_39208 | |
| 4-methylhistamine | CHEBI_74760 | [An aralkylamino compound that is histamine bearing a methyl substituent at the 5 position on the ring.] |
| histamine agonist | CHEBI_35678 | [A drug that binds to and activates histamine receptors. Although they have been suggested for a variety of clinical applications, histamine agonists have so far been more widely used in research than therapeutically.] |
| CHEBI_49783 | CHEBI_49783 | |
| 2-methylhistamine | CHEBI_74761 | [An aralkylamino compound that is histamine bearing a methyl substituent at the 2 position on the ring.] |
| Pro-Glu | CHEBI_74762 | [A dipeptide formed from L-proline and L-glutamic acid residues.] |
| CHEBI_49785 | CHEBI_49785 | |
| 1,3-dimethyluracil | CHEBI_74763 | [A pyrimidone that is uracil with methyl group substituents at positions 1 and 3.] |
| nickel(2+) | CHEBI_49786 | [A nickel cation in which the nickel carries a double positive charge.] |
| 4-fluoro-N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide | CHEBI_106968 | |
| CHEBI_49787 | CHEBI_49787 | |
| 1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea | CHEBI_106969 |